Stockscreener 앱 받기
0.9885
2.44%
0.0235
시간 외 거래:
.96
-0.0285
-2.88%
전일 마감가:
$0.965
열려 있는:
$0.96
하루 거래량:
891.33K
Relative Volume:
0.14
시가총액:
$48.04M
수익:
$1.14M
순이익/손실:
$-56.27M
주가수익비율:
-0.8143
EPS:
-1.2139
순현금흐름:
$-51.94M
1주 성능:
+4.74%
1개월 성능:
+158.77%
6개월 성능:
+33.58%
1년 성능:
-29.89%
1일 변동 폭
$0.9501
$0.9885
1주일 범위
$0.9301
$0.99
52주 변동 폭
$0.27
$2.38
웨어울프 테라 Stock (HOWL) Company Profile
명칭
Werewolf Therapeutics Inc
전화
617-952-0555
주소
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.9885 | 46.90M | 1.14M | -56.27M | -51.94M | -1.2139 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
웨어울프 테라 Stock (HOWL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-04-03 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-24 | 개시 | Wedbush | Outperform |
| 2023-06-06 | 재개 | Jefferies | Buy |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-05-25 | 개시 | Evercore ISI | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
| 2021-05-25 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | SVB Leerink | Outperform |
모두보기
웨어울프 테라 주식(HOWL)의 최신 뉴스
Werewolf Therapeutics (HOWL) Dips 1.43% to $0.97 as Tight Trading Range Sends Stock Toward Key SupportEarnings Miss Risk - dars.gov.et
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
HOWL|Werewolf Therapeutics Inc|Price:0.980|Chg%:+0.014 - TradingKey
Werewolf Therapeutics Stock Price Forecast. Should You Buy HOWL? - StockInvest.us
Werewolf Therapeutics stock gains on merger scrutiny and trial progress - ad-hoc-news.de
Werewolf Therapeutics Completes Key Early Trial For WTX-124 In Hard-To-Treat Cancers - TipRanks
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the MergerHOWL, HZO, TYFG and FULC - Sahm
Werewolf (HOWL) Outlook: Moves 102.57% Up to $0.87 in the Latest Reading; Boundary Watch: $0.83 and $0.91 Define the Nearby Reference Levels at the CloseMoving Average Ribbon - vinanet.vn
Werewolf and Ambros Therapeutics announce merger - The Pharma Letter
Werewolf Therapeutics (NASDAQ:HOWL) Deal Changes Pipeline Focus - Kalkine Media
Werewolf Therapeutics Shares Surge Twofold After Ambros Merger, Investors Retain 6.8% Stake - TechStock²
Latham Watkins Advises on Oversubscribed Private Placement in Werewolf Ambros Merger Transaction - Latham & Watkins LLP
Werewolf Therapeutics, Inc. announced that it expects to receive $150 million in funding - marketscreener.com
Werewolf Therapeutics Strikes Reverse Merger With Ambros, Secures $150 Million for Rare Pain Drug - finance.biggo.com
Trending Stocks Today | Werewolf Therapeutics Shoots up 117.27% - Moomoo
Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News - Yahoo Finance
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Watertown biotech agrees to reverse merger with Vivek Ramaswamy-backed startup - The Business Journals
Gold Moves Higher; US Composite PMI Surges In August - Benzinga
Werewolf Therapeutics (HOWL) Stock Soars 127% on Ambros Merger and $150M Financing Deal - Blockonomi
Werewolf Therapeutics stock soars on Ambros merger deal and $150 million PIPE - Quiver Quantitative
Why is Werewolf Therapeutics stock surging more than 100% today? By Investing.com - Investing.com Canada
Ambros Therapeutics to merge with Werewolf Therapeutics in all-stock deal - Dealroom
Why is Werewolf Therapeutics stock surging more than 100% today? - Investing.com
Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug - Fierce Biotech
Why Is Werewolf Therapeutics Stock Gaining Friday?Werewolf Therapeutics (NASDAQ:HOWL) - Benzinga
Israel Englander's HOWL Stock Soars on $500M DealWerewolf Therapeutics (NASDAQ:HOWL) - Benzinga
Werewolf Therapeutics to Merge and Rebrand as Ambros - TipRanks
Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing - Yahoo Finance
HOWL Stock Whipsaws As One-Off Profit Meets Uncertain Future - StocksToTrade
Why Is Penny Stock Werewolf Therapeutics (HOWL) Up Today? - TipRanks
Werewolf (NASDAQ: HOWL) Ambros deal leaves holders with single-digit stake - Stock Titan
Werewolf Therapeutics to Merge With Ambros in Stock Deal; Raises $150 Million PIPE, Holders Locked Up - TradingView
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement - Investing News Network
Werewolf Therapeutics stock soars 120% on Ambros merger deal - Investing.com
HOWL Stock Jumps As One-Off Deal Reshapes Outlook - StocksToTrade
HOWL Stock Jumps As One-Time Deal Fuels Q2 Profit - timothysykes.com
Werewolf Therapeutics to merge with Ambros in $150m deal - Investing.com
Werewolf Therapeutics, Ambros Therapeutics Plan Merger With $150 Million Financing - citybiz
Werewolf Therapeutics to merge with Ambros in $150m deal By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Werewolf Therapeutics and Ambros Therapeutics Announce - GlobeNewswire
Top Premarket Gainers - marketscreener.com
Great couple of days trading this!! 🐺 📊 📚 - Moomoo
Werewolf Therapeutics Shares Surge 89.94% After Hours on EMD Serono DealWerewolf Therapeutics (NASDAQ - Benzinga
Werewolf (HOWL) Update: Climbs 5.35% to $0.43 in Latest Trading; Price Levels: the Supplied Trading Band Runs From $0.41 to $0.45 for the Current SessionIchimoku Kumo Break - vinanet.vn
Werewolf Therapeutics Sells Pre-Clinical Platforms to EMD for $33 Million - Minichart
Trending Stocks Today | Werewolf Therapeutics Soars 90.16% Post-Market - Moomoo
Werewolf Therapeutics Monetizes Platforms, Refocuses on Lead Programs - TipRanks
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Werewolf TherapeuticsOn August 14, Sells Inducer And Indukine Platforms To Emd Serono - TradingView
웨어울프 테라 (HOWL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.04%
자본화:
|
볼륨(24시간):